mAbxience Selects Genedata Bioprocess to Automate End-to-End CDMO Workflows [Yahoo! Finance]
FRESENIUS SE S/ADR (FSNUY)
NASDAQ:AMEX Investor Relations:
fresenius.com/index
Company Research
Source: Yahoo! Finance
Purpose-built enterprise SaaS solution streamlines bioprocess workflows and accelerates digital transformation for global biopharmaceutical development BASEL, Switzerland March 10, 2026 /PRNewswire/ -- Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that mAbxience has selected the Genedata Bioprocess ® enterprise platform to structure and harmonize all bioprocess development data across its operations. mAbxience, majority-owned by the Fresenius Kabi group, is a global Contract Development and Manufacturing Organization (CDMO) specializing in the manufacture of biosimilars. "With our growing biosimilars portfolio and increasing complexity in bioprocess development, we needed a single, integrated platform that connects and analyzes all data across upstream, downstream, cell line, formulation, and analytical development," said Ivan Sánchez de Melo, Ph.D., R&D Director. "Genedata Bioprocess, operated in
Show less
Read more
Impact Snapshot
Event Time:
FSNUY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FSNUY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FSNUY alerts
High impacting FRESENIUS SE S/ADR news events
Weekly update
A roundup of the hottest topics
FSNUY
News
- Fresenius Kabi and Phlow Corp. Announce First-Ever, End-to-End, U.S. Manufacturing Collaboration for Epinephrine Injection, USP [Yahoo! Finance]Yahoo! Finance
- Fresenius SE & Co. (OTCMKTS:FSNUY) had its "buy" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- Fresenius Kabi Recognized as a Top Employer in the United States for the Fourth Consecutive Year [Yahoo! Finance]Yahoo! Finance
- Aspen Surgical Appoints Jørgen B. Hansen as Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
- Fresenius Kabi Introduces New Presentation of Otulfi® (ustekinumab-aauz), a Biosimilar to Stelara® [Yahoo! Finance]Yahoo! Finance